UNSPSC 51152005: Botulinum toxin

This classification denotes a peripherally-acting muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E211KPY694.

UNSPSC 51152005 Botulinum toxin is a Commodity code that state and local health agencies use to procure specialized pharmaceutical products, though recent solicitation activity under this specific code shows limited matches to the nominal scope. The Mississippi State Department of Health posted a sole source notice in July 2026, but the opportunity concerns Yellow Fever Vaccine procurement from Sanofi Pasteur, Inc., not botulinum toxin products. State and local health departments represent the primary issuing bodies for codes in this family, with purchases typically driven by immunization programs, public health emergencies, and disease prevention initiatives that require single-source or restricted-source procurement when therapeutic or vaccine supply is limited to one qualified vendor.

The source provides no additional geographic distribution or representative opportunities directly aligned with botulinum toxin procurement. The sole documented recent activity—the Mississippi State Department of Health's Yellow Fever Vaccine sole source notice with an objection deadline of August 3, 2026—indicates that health agency procurement under this code tier may be sparse or may be tagged inconsistently across state and local systems. Firms pursuing work under this code should monitor state health department procurement channels and cooperative purchasing vehicles for immunization and pharmaceutical contracts, but should note that actual purchasing patterns may diverge from the code's nominal scope and that sole source designations in this space are subject to public objection and review board scrutiny.